Detalles de la búsqueda
1.
Front-line and second-line treatment for mantle cell lymphoma in clinical practice: A multicenter retrospective analysis.
Eur J Haematol
; 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661269
2.
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020.
Br J Haematol
; 201(1): 64-74, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36513500
3.
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events.
Cancer Immunol Immunother
; 72(10): 3337-3347, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486396
4.
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.
Breast Cancer Res Treat
; 201(2): 183-192, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37428418
5.
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors.
BMC Cancer
; 23(1): 1186, 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049762
6.
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis.
BMC Cancer
; 22(1): 236, 2022 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35241020
7.
Rapid diagnosis and initiation of treatment has a crucial role in the prognosis of primary central nervous system lymphoma.
Br J Haematol
; 203(2): e78-e81, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519227
8.
Characterization of human memory CD4(+) T-cell responses to the dog allergen Can f 4.
J Allergy Clin Immunol
; 136(4): 1047-54.e10, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25843313
9.
High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer.
Cancers (Basel)
; 16(3)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339385
10.
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy.
Clin Lung Cancer
; 24(4): 295-304, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774235
11.
Blood-Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study.
Cancers (Basel)
; 15(4)2023 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831682
12.
The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma.
Front Oncol
; 11: 811434, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35127523
13.
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria.
Hemasphere
; 7(10): e954, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37693119
Resultados
1 -
13
de 13
1
Próxima >
>>